REPLIMUNE GROUP, INC. Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent
REPLIMUNE GROUP, INC. (REPL) reported Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent of $582.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent · last filed 2026-08-14
- REPLIMUNE GROUP, INC. other comprehensive income (loss), foreign currency transaction and translation adjustment, net of tax, portion attributable to parent for the quarter ending 2026-06-30 was $582.00K.
- REPLIMUNE GROUP, INC. other comprehensive income (loss), foreign currency transaction and translation adjustment, net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$40.00K.
- REPLIMUNE GROUP, INC. other comprehensive income (loss), foreign currency transaction and translation adjustment, net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $482.00K, a 84.50% decline year-over-year.
- REPLIMUNE GROUP, INC. other comprehensive income (loss), foreign currency transaction and translation adjustment, net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $751.00K.
- REPLIMUNE GROUP, INC. other comprehensive income (loss), foreign currency transaction and translation adjustment, net of tax, portion attributable to parent for fiscal 2026 was $255.00K, a 46.55% increase from fiscal 2025.
- REPLIMUNE GROUP, INC. other comprehensive income (loss), foreign currency transaction and translation adjustment, net of tax, portion attributable to parent for fiscal 2025 was $174.00K.
- REPLIMUNE GROUP, INC. other comprehensive income (loss), foreign currency transaction and translation adjustment, net of tax, portion attributable to parent for fiscal 2024 was -$826.00K, a 115.06% decline from fiscal 2023.
- REPLIMUNE GROUP, INC. other comprehensive income (loss), foreign currency transaction and translation adjustment, net of tax, portion attributable to parent for fiscal 2023 was $5.48M, a 633.02% increase from fiscal 2022.
| Period end | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | $582.00K 10-Q · filed 2026-08-14 | $542.00K derived: sum of 2 quarters · filed 2026-08-14 | $1.02M derived: sum of 3 quarters · filed 2026-08-14 | $1.77M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | $442.00K derived: sum of 2 quarters · filed 2026-06-29 | $1.19M derived: sum of 3 quarters · filed 2026-06-29 | $255.00K 10-K · filed 2026-06-29 |
| 2025-12-31 | $482.00K 10-Q · filed 2026-02-03 | $1.23M derived: sum of 2 quarters · filed 2026-02-03 | $295.00K 10-Q · filed 2026-02-03 | -$304.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-09-30 | $751.00K 10-Q · filed 2026-02-03 | -$187.00K 10-Q · filed 2025-11-06 | -$786.00K derived: sum of 3 quarters · filed 2026-08-14 | $2.32M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$938.00K 10-Q · filed 2026-08-14 | -$1.54M derived: sum of 2 quarters · filed 2026-08-14 | $1.57M derived: sum of 3 quarters · filed 2026-08-14 | -$332.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$599.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | $2.51M derived: sum of 2 quarters · filed 2026-06-29 | $606.00K derived: sum of 3 quarters · filed 2026-06-29 | $174.00K 10-K · filed 2026-06-29 |
| 2024-12-31 | $3.11M 10-Q · filed 2026-02-03 | $1.21M derived: sum of 2 quarters · filed 2026-02-03 | $773.00K 10-Q · filed 2026-02-03 | $1.23M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-09-30 | -$1.91M 10-Q · filed 2026-02-03 | -$2.34M 10-Q · filed 2025-11-06 | -$1.88M derived: sum of 3 quarters · filed 2026-02-03 | -$3.17M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-06-30 | -$432.00K 10-Q · filed 2026-02-03 | $27.00K derived: sum of 2 quarters · filed 2026-02-03 | -$1.26M derived: sum of 3 quarters · filed 2026-02-03 | $47.00K derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-03-31 | $459.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-22 | -$829.00K derived: sum of 2 quarters · filed 2025-05-22 | $479.00K derived: sum of 3 quarters · filed 2025-05-22 | -$826.00K 10-K · filed 2025-05-22 |
| 2023-12-31 | -$1.29M 10-Q · filed 2025-02-12 | $20.00K derived: sum of 2 quarters · filed 2025-02-12 | -$1.28M 10-Q · filed 2025-02-12 | -$27.00K derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-09-30 | $1.31M 10-Q · filed 2025-02-12 | $3.00K 10-Q · filed 2024-11-12 | $1.26M derived: sum of 3 quarters · filed 2025-02-12 | $1.42M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | -$1.30M 10-Q · filed 2025-02-12 | -$47.00K derived: sum of 2 quarters · filed 2025-02-12 | $111.00K derived: sum of 3 quarters · filed 2025-02-12 | $2.44M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-16 | $1.42M derived: sum of 2 quarters · filed 2024-05-16 | $3.75M derived: sum of 3 quarters · filed 2024-05-16 | $5.48M 10-K · filed 2024-05-16 |
| 2022-12-31 | $158.00K 10-Q · filed 2024-02-08 | $2.49M derived: sum of 2 quarters · filed 2024-02-08 | $4.22M 10-Q · filed 2024-02-08 | $4.37M derived: sum of 4 quarters · filed 2024-02-08 |
| 2022-09-30 | $2.33M 10-Q · filed 2024-02-08 | $4.07M 10-Q · filed 2023-11-07 | $4.21M derived: sum of 3 quarters · filed 2024-02-08 | $4.37M derived: sum of 4 quarters · filed 2024-02-08 |
| 2022-06-30 | $1.74M 10-Q · filed 2024-02-08 | $1.88M derived: sum of 2 quarters · filed 2024-02-08 | $2.04M derived: sum of 3 quarters · filed 2024-02-08 | $2.26M derived: sum of 4 quarters · filed 2024-02-08 |
| 2022-03-31 | $144.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-18 | $305.00K derived: sum of 2 quarters · filed 2023-05-18 | $524.00K derived: sum of 3 quarters · filed 2023-05-18 | $748.00K 10-K · filed 2023-05-18 |
| 2021-12-31 | $161.00K 10-Q · filed 2023-02-09 | $380.00K derived: sum of 2 quarters · filed 2023-02-09 | $604.00K 10-Q · filed 2023-02-09 | $308.00K derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-09-30 | $219.00K 10-Q · filed 2023-02-09 | $443.00K 10-Q · filed 2022-11-03 | $147.00K derived: sum of 3 quarters · filed 2023-02-09 | $695.00K derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-06-30 | $224.00K 10-Q · filed 2023-02-09 | -$72.00K derived: sum of 2 quarters · filed 2023-02-09 | $476.00K derived: sum of 3 quarters · filed 2023-02-09 | $1.10M derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-03-31 | -$296.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-19 | $252.00K derived: sum of 2 quarters · filed 2022-05-19 | $878.00K derived: sum of 3 quarters · filed 2022-05-19 | $866.00K 10-K · filed 2022-05-19 |
| 2020-12-31 | $548.00K 10-Q · filed 2022-02-03 | $1.17M derived: sum of 2 quarters · filed 2022-02-03 | $1.16M 10-Q · filed 2022-02-03 | $918.00K derived: sum of 4 quarters · filed 2022-02-03 |
| 2020-09-30 | $626.00K 10-Q · filed 2022-02-03 | $614.00K 10-Q · filed 2021-11-04 | $370.00K derived: sum of 3 quarters · filed 2022-02-03 | $778.00K derived: sum of 4 quarters · filed 2022-02-03 |
| 2020-06-30 | -$12.00K 10-Q · filed 2022-02-03 | -$256.00K derived: sum of 2 quarters · filed 2022-02-03 | $152.00K derived: sum of 3 quarters · filed 2022-02-03 | -$66.00K derived: sum of 4 quarters · filed 2022-02-03 |
| 2020-03-31 | -$244.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-20 | $164.00K derived: sum of 2 quarters · filed 2021-05-20 | -$54.00K derived: sum of 3 quarters · filed 2021-05-20 | -$236.00K 10-K · filed 2021-05-20 |
| 2019-12-31 | $408.00K 10-Q · filed 2021-02-04 | $190.00K derived: sum of 2 quarters · filed 2021-02-04 | $8.00K 10-Q · filed 2021-02-04 | $199.00K derived: sum of 4 quarters · filed 2021-02-04 |
| 2019-09-30 | -$218.00K 10-Q · filed 2021-02-04 | -$400.00K 10-Q · filed 2020-11-05 | -$209.00K derived: sum of 3 quarters · filed 2021-02-04 | -$311.00K derived: sum of 4 quarters · filed 2021-02-04 |
| 2019-06-30 | -$182.00K 10-Q · filed 2021-02-04 | $9.00K derived: sum of 2 quarters · filed 2021-02-04 | -$93.00K derived: sum of 3 quarters · filed 2021-02-04 | -$232.00K derived: sum of 4 quarters · filed 2021-02-04 |
| 2019-03-31 | $191.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-03 | $89.00K derived: sum of 2 quarters · filed 2020-06-03 | -$50.00K derived: sum of 3 quarters · filed 2020-06-03 | -$897.00K 10-K · filed 2020-06-03 |
| 2018-12-31 | -$102.00K 10-Q · filed 2020-02-13 | -$241.00K derived: sum of 2 quarters · filed 2020-02-13 | -$1.09M 10-Q · filed 2020-02-13 | -$400.00K derived: sum of 4 quarters · filed 2020-06-03 |
| 2018-09-30 | -$139.00K 10-Q · filed 2020-02-13 | -$986.00K 10-Q · filed 2019-11-12 | -$298.00K derived: sum of 3 quarters · filed 2020-06-03 | -$187.00K derived: sum of 4 quarters · filed 2020-06-03 |
| 2018-06-30 | -$847.00K 10-Q · filed 2020-02-13 | -$159.00K derived: sum of 2 quarters · filed 2020-06-03 | -$48.00K derived: sum of 3 quarters · filed 2020-06-03 | $576.00K derived: sum of 4 quarters · filed 2020-06-03 |
| 2018-03-31 | $688.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-03 | $799.00K derived: sum of 2 quarters · filed 2020-06-03 | $1.42M derived: sum of 3 quarters · filed 2020-06-03 | $2.38M 10-K · filed 2020-06-03 |
| 2017-12-31 | $111.00K 10-Q · filed 2019-02-14 | $735.00K derived: sum of 2 quarters · filed 2019-02-14 | $1.69M 10-Q · filed 2019-02-14 | |
| 2017-09-30 | $624.00K 10-Q · filed 2018-11-14 | $1.58M 10-Q · filed 2018-11-14 | ||
| 2017-06-30 | $953.00K 10-Q · filed 2018-08-30 | |||
| 2017-03-31 | -$1.44M 10-K · filed 2019-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B |